{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/desferrioxamine",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/desferrioxamine#bnf_i1643857952170",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/desferrioxamine#bnf_i1643857952170_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"ascorbic acid\" outputclass=\"int-drug\">Ascorbic acid</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of cardiovascular adverse effects when given with</ph> <ph otherprops=\"desferrioxamine\" outputclass=\"int-heading-drug\">desferrioxamine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution or adjust ascorbic acid dose; monitor cardiac function and avoid concurrent use in those with cardiac failure</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Ascorbic acid   might   increase   the risk of cardiovascular adverse effects when given with   desferrioxamine .  Manufacturer advises caution or adjust ascorbic acid dose; monitor cardiac function and avoid concurrent use in those with cardiac failure .    \n\n"
						}
					],
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ascorbic acid</title>"
					}
				}
			],
			"hasSearchLabel": " Desferrioxamine  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/desferrioxamine.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Desferrioxamine </title>"
			},
			"rdfs:label": "desferrioxamine"
		}
	]
}